The rapid evolution of clinical intelligence has reached a critical juncture where the traditional boundaries of medical practice and digital intervention are becoming permanently intertwined. As healthcare systems across the United States increasingly rely on sophisticated algorithms to manage everything from patient triage to diagnostic imaging, the American Hospital Association has issued a definitive call for a modernized regulatory framework that reflects the realities of 2026. In a comprehensive response to a Request for Information from the Department of Health and Human Services, the association, which represents nearly five thousand hospitals and hundreds of thousands of clinicians, emphasized that the current patchwork of rules is no longer sufficient to govern the complexities of artificial intelligence. The message is clear: while the potential for improving patient outcomes and reducing administrative burdens is immense, the lack of a cohesive federal strategy threatens to stifle innovation and compromise the stability of the national healthcare infrastructure. This formal advocacy marks a shift from viewing technology as a peripheral tool to recognizing it as a fundamental component of the clinical environment that requires its own tailored legal and financial protections.
Artificial intelligence has already moved beyond the realm of theoretical experimentation and is now actively performing high-impact tasks within the hallways of modern medical facilities. Tools such as ambient listening systems are currently transforming the way physicians interact with patients by automating the once-cumbersome process of clinical documentation, thereby allowing providers to focus on the human element of care. In the radiology department, advanced algorithms are interpreting complex images with a level of precision that assists specialists in catching subtle anomalies earlier than ever before. Despite these successes, the American Hospital Association warns that the absence of a synchronized policy environment creates unnecessary risks for both providers and patients. To bridge this gap, the association proposes a “flexible yet safe” approach that avoids the creation of redundant layers of bureaucracy while ensuring that every digital tool implemented in a clinical setting is subject to rigorous, transparent, and consistent standards. By harmonizing new policies with established healthcare frameworks, the government can foster an ecosystem where innovation and safety coexist without the burden of conflicting mandates.
Establishing Regulatory Synchronization with Established Standards
A primary pillar of the recommendation provided to federal authorities involves the deliberate alignment of artificial intelligence policy with existing frameworks such as the Health Insurance Portability and Accountability Act. Because the functionality of any clinical algorithm is entirely dependent on the quality and accessibility of data, maintaining a single, gold-standard privacy requirement is essential for operational clarity. The association maintains that creating competing or fragmented privacy mandates would only serve to confuse developers and healthcare providers, potentially leading to accidental non-compliance and a decrease in the overall security of patient information. By anchoring artificial intelligence regulations within the proven structure of current privacy laws, the government can provide a stable foundation that encourages long-term investment in digital health solutions. This approach ensures that as technology evolves, the core principles of patient confidentiality and data integrity remain uncompromised, regardless of the complexity of the underlying software.
The association further highlights the critical need for federal preemption regarding data privacy laws to eliminate the current inconsistencies that plague the healthcare industry. At present, providers must navigate a confusing landscape of state-specific regulations that often conflict with one another, making it difficult to share the large datasets required to train and validate robust clinical algorithms. A unified federal standard would streamline the development process and allow for the more effective implementation of life-saving technologies across state lines. Furthermore, the modernization of 42 CFR Part 2 is seen as a vital step in this process, as the current isolation of substance use disorder records prevents integrated systems from achieving a “whole-person” view of patient health. Removing these regulatory silos is necessary to allow artificial intelligence to analyze a patient’s complete medical history, which is often the key to providing accurate diagnoses and personalized treatment plans in high-stakes clinical scenarios.
Protecting the Human-in-the-Loop Standard for Clinical Decisions
One of the most pressing concerns raised in the recent feedback to the Department of Health and Human Services involves the increasing use of automated systems by commercial insurers to expedite claim denials and prior authorizations. There is significant evidence suggesting that some payers are utilizing algorithms to make medical necessity determinations without sufficient human oversight, often leading to the delay or denial of essential treatments. The American Hospital Association emphasizes that while artificial intelligence can certainly assist with administrative speed, it must never be allowed to serve as the final arbiter of medical care. The association strongly advocates for a “human-in-the-loop” requirement for all insurance-related applications, ensuring that any negative determination is reviewed by a qualified clinician with expertise relevant to the specific condition of the patient. This safeguard is intended to prevent software from overriding professional medical judgment and to ensure that patient care remains the top priority.
Transparency serves as a major component of this proposed oversight, as both healthcare providers and patients frequently find themselves excluded from the logic used by automated insurance systems. When an algorithm recommends a denial of care, the reasoning behind that decision is often hidden within a proprietary “black box,” leaving the clinical team with no clear path to appeal or understand the determination. The association insists that insurers and technology developers must be required to provide visibility into their decision-making processes, ensuring that all clinical actions remain grounded in evidence-based medicine rather than opaque algorithmic calculations. By mandating transparency, the federal government can help maintain the integrity of the patient-provider relationship and ensure that technology serves as a supportive tool rather than an automated barrier to necessary medical intervention. This push for clarity is not just about fairness; it is about ensuring that the medical community can trust the digital systems that are increasingly influencing the trajectory of patient care.
Ensuring Economic Sustainability for Modern Hospital Systems
The financial reality of the modern hospital system is a central factor in the current policy discussion, particularly as Medicare reimbursements continue to fall short of the actual cost of providing care. With many facilities operating on razor-thin margins, the introduction of expensive new technologies presents a significant economic challenge that must be addressed through modernized payment models. The association argues that reimbursement for artificial intelligence tools should not be “budget neutral,” meaning that the funding for these innovations must not be taken from other essential medical services. If the government expects hospitals to adopt and maintain sophisticated digital infrastructures, it must provide the financial support necessary to do so without compromising the quality of traditional bedside care. The sustainability of the entire healthcare system depends on a reimbursement strategy that recognizes the unique value and the unique costs associated with high-tech clinical interventions.
There are several often-overlooked expenses associated with the lifecycle of clinical intelligence that the association believes must be factored into future payment calculations. Beyond the initial purchase price, hospitals must invest significant time and resources into the clinical validation of outputs, software licensing, and the vast amounts of secure data storage required to run these systems. Additionally, the escalating cost of cybersecurity insurance has become a major burden as facilities increase their reliance on Software as a Service models and other digital tools. The association suggests that these rising premiums should be treated similarly to malpractice insurance in reimbursement formulas, reflecting the necessary cost of maintaining a secure and functional medical environment in 2026. Without these financial adjustments, the push for digital transformation could inadvertently lead to a widening gap between wealthy health systems and those serving vulnerable populations, as only the most well-funded institutions would be able to afford the ongoing costs of innovation.
Bridging the Digital Infrastructure Divide in Underserved Areas
A significant portion of the association’s advocacy focuses on the fact that the benefits of clinical artificial intelligence are currently distributed unevenly across the United States. In many rural and underserved urban communities, the lack of reliable high-speed broadband and robust Wi-Fi networks creates a “digital divide” that prevents these areas from accessing the latest medical advancements. If the underlying infrastructure is missing, these communities will inevitably be left behind as the rest of the healthcare system shifts toward a more data-driven model of care. The American Hospital Association urges the Department of Health and Human Services to collaborate with other federal agencies, such as the FCC and the Department of Commerce, to prioritize investment in connectivity for healthcare facilities. This is not merely a technical issue but a fundamental matter of health equity, as a patient’s geographic location should not determine their access to life-saving technology.
Furthermore, the association points out that technical connectivity is only one part of the equation, as digital literacy for both patients and providers is equally essential for the successful implementation of new tools. Federal support should include funding for training programs that help clinicians understand how to effectively integrate artificial intelligence into their daily workflows without increasing their administrative burden. For patients, particularly those in marginalized communities, education on how to use digital health platforms is necessary to ensure that they can participate fully in their own care. Without a solid foundation of both infrastructure and education, the adoption of advanced clinical tools risks exacerbating existing health disparities rather than solving them. The association believes that a coordinated federal effort is required to ensure that the transition to a more digital healthcare system is inclusive and that the promise of artificial intelligence is realized for every patient, regardless of their socioeconomic status.
Shifting Accountability Toward Technology Vendors and Developers
The “black box” nature of many modern algorithms presents a unique and growing challenge for healthcare providers who are ultimately responsible for patient safety. When the internal logic of a diagnostic or predictive tool is hidden from the user, it becomes nearly impossible for hospital IT departments and clinicians to identify potential flaws or “model drift,” where a tool becomes less accurate over time due to changes in patient populations or data quality. The American Hospital Association argues that the legal and ethical responsibility for the integrity of these tools must shift toward the developers who create and profit from them. Hospitals should not be expected to bear the entire burden of monitoring the performance metrics of proprietary software that they do not fully control. Instead, vendors must be held to the same rigorous standards of privacy, security, and ongoing validation that are currently applied to the healthcare facilities themselves.
By increasing vendor accountability, the federal government can help create a more transparent and competitive marketplace for clinical technology. The association suggests that developers should be required to provide ongoing performance data and evidence of clinical validity as a standard part of their service agreements. This would allow hospital leadership to make more informed decisions about which tools to implement and would provide a clear path for addressing issues when an algorithm fails to meet its promised standards. This shift in the balance of responsibility is essential for maintaining the trust of both clinicians and patients, as it ensures that the companies driving technological innovation are also invested in the long-term safety and efficacy of their products. Establishing a clear framework for vendor liability and transparency will help eliminate the current “liability vacuum” that often leaves hospitals and individual practitioners vulnerable to legal repercussions for errors caused by faulty software.
Reforming Cybersecurity Policy and Moving Away from Punitive Measures
In response to the increasing frequency of sophisticated cyberattacks targeting the healthcare sector, the association has expressed strong opposition to recent proposals that would impose punitive measures on hospitals. Specifically, the association critiques mandates that would require systems to be restored within an arbitrary and often unrealistic seventy-two-hour window following a breach. Such rigid requirements could inadvertently force a hospital to bring its digital systems back online before a threat has been fully neutralized, potentially leading to even more severe data loss or system failure. Instead of focusing on fines and penalties, the association advocates for a collaborative model that recognizes healthcare facilities as victims of professional, often state-sponsored, hacking groups. The focus of federal policy should be on strengthening the entire digital ecosystem, including the third-party vendors who are frequently the primary targets or entry points for large-scale data breaches.
The association maintains that cybersecurity standards should remain voluntary and based on established, flexible frameworks like the NIST standards, rather than being dictated by static and punitive regulations. By working together with the government to share threat intelligence and best practices, healthcare providers can build a more resilient defense against the evolving threats that target the nation’s medical infrastructure. A cooperative approach encourages transparency and allows hospitals to direct their limited resources toward actual security improvements rather than legal fees or government fines. Furthermore, the association calls for federal support in developing a more robust workforce of cybersecurity professionals who specialize in the unique needs of the healthcare industry. By prioritizing resilience and collaboration over punishment, the government can help ensure that hospitals remain safe environments for patient care, even as they navigate an increasingly dangerous digital landscape.
Defining the Future Role of the FDA in Algorithmic Oversight
The American Hospital Association supports the continued role of the FDA in overseeing “Software as a Medical Device” but emphasizes the need for a more nuanced, risk-based oversight model. Not every digital tool used in a hospital carries the same level of risk to patient safety, and a one-size-fits-all regulatory approach could unnecessarily slow down the adoption of helpful administrative applications. The association proposes that the level of government monitoring and evaluation should correspond directly to the potential impact of the tool on clinical outcomes. This would allow for rigorous and frequent checks on high-stakes diagnostic algorithms while remaining more flexible for low-risk tools designed for scheduling, documentation, or basic clinical decision support. This balanced approach ensures that resources are directed where they are most needed to protect patients without creating barriers to the development of tools that can reduce clinician burnout.
Post-deployment monitoring is another area where the association seeks a middle-ground solution that ensures long-term safety without being overly burdensome. While it is necessary to monitor algorithms for signs of drift or bias after they have been implemented in a real-world setting, the requirements for this surveillance should be practical and sustainable for both developers and providers. Periodic revalidation and the use of standardized performance metrics can provide the necessary oversight without requiring the constant, labor-intensive reporting that would stifle further innovation. Additionally, the association has requested clearer guidance on the legal distinction between clinical and administrative artificial intelligence, as the lines between these categories continue to blur. Providing non-binding FAQs and specific use cases would help hospitals navigate the different regulatory requirements for various technologies, ensuring that they remain in compliance while continuing to push the boundaries of what is possible in modern medical practice.
Addressing the Liability Vacuum and Establishing Legal Clarity
A significant and unresolved concern for the healthcare community is the lack of legal clarity regarding errors that may be generated by artificial intelligence. In a scenario where a clinician follows a flawed recommendation from an algorithm that results in patient harm, the current legal framework does not clearly define where the liability lies—with the software developer or the healthcare provider. This uncertainty creates a significant risk for practitioners and health systems, potentially discouraging the adoption of life-saving tools due to the fear of undefined legal repercussions. The American Hospital Association has urged the federal government to establish clear standards for developer transparency and liability to mitigate these risks. When providers have a complete understanding of the training data and the known limitations of an algorithm, they are better equipped to exercise the professional judgment that remains the ultimate safeguard for patient safety.
To further stabilize the technology market, the association suggests the establishment of a voluntary certification process for vendors, which would allow hospitals to more easily vet startups and ensure that their products meet baseline security and functionality standards. Such a system would significantly reduce the administrative and technical burden on individual hospital IT departments, which often lack the resources to perform deep technical audits on every new piece of software. Clearer legal guidelines and a standardized certification process would provide the stability needed for hospitals to fully embrace artificial intelligence as a core part of their clinical strategy. By addressing the liability vacuum now, the government can ensure that the legal system supports rather than hinders the digital transformation of medicine. This proactive approach to legal reform is seen as a necessary step in creating a sustainable environment where technology and human expertise can work in tandem to improve the lives of patients across the country.
Highlighting Practical Successes and Learning from Systematic Failures
The American Hospital Association has provided concrete examples of where artificial intelligence is currently succeeding and where it is falling short, offering a roadmap for future policy adjustments. Successes in areas like ambient listening and radiology are already proving that technology can significantly reduce the administrative workload on clinicians and improve the accuracy of early diagnoses. These “wins” demonstrate the transformative power of digital tools when they are implemented thoughtfully and supported by adequate infrastructure. However, the association also points to systemic failures, particularly the high rate of overturned insurance denials, as a sign that the current use of automated tools by payers is often inaccurate and counterproductive. These failures create significant administrative waste and, more importantly, delay necessary care for patients, highlighting the urgent need for stricter oversight of how financial stakeholders utilize these powerful technologies.
The transition to a more data-driven healthcare environment required a fundamental rethinking of the relationship between technology, policy, and practice. The American Hospital Association advocated for a regulatory landscape that prioritized transparency, clinical validity, and the preservation of the patient-provider relationship. Stakeholders across the industry recognized that the successful integration of artificial intelligence depended on a collaborative effort to remove outdated regulatory silos and provide equitable access to digital infrastructure. By focusing on risk-based oversight and shifting accountability toward developers, the medical community moved toward a future where algorithms served as a supportive engine for care rather than a source of instability. These actions ensured that the healthcare system remained resilient, financially sustainable, and focused on the primary goal of improving patient health through the responsible application of modern clinical intelligence.
